DILTIAZEM TEVA 30 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

DILTIAZEM HYDROCHLORIDE

متاح من:

TEVA ISRAEL LTD

ATC رمز:

C08DB01

الشكل الصيدلاني:

TABLETS

تركيب:

DILTIAZEM HYDROCHLORIDE 30 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

المجموعة العلاجية:

DILTIAZEM

المجال العلاجي:

DILTIAZEM

الخصائص العلاجية:

Calcium channel blocker for the treatment of angina pectoris.

تاريخ الترخيص:

2014-04-30

نشرة المعلومات

THIS LEAFLET FORMAT HAS BEEN
DETERMINED BY THE MINISTRY OF HEALTH
AND THE CONTENT THEREOF HAS BEEN
CHECKED AND APPROVED IN JUNE 2016
PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with
a doctor’s prescription only
DILTIAZEM TEVA
® 30 MG
TABLETS
THE ACTIVE INGREDIENT AND ITS QUANTITY:
Each tablet contains:
Diltiazem hydrochloride 30 mg
DILTIAZEM TEVA
® 60 MG
TABLETS
THE ACTIVE INGREDIENT AND ITS QUANTITY:
Each tablet contains:
Diltiazem hydrochloride 60 mg
For the list of inactive ingredients, please
see section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the
medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed for the
treatment of your ailment. Do not pass this
medicine on to others. It may harm them
even if it seems to you that their medical
condition is similar.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended for the treatment
of angina pectoris.
THERAPEUTIC GROUP:
Calcium channel blocker.
2. BEFORE USING THE MEDICINE: DO NOT USE THE PREPARATION IN THE
FOLLOWING CASES:
∙ If you are breastfeeding or are planning
to breastfeed.
∙ If you have a known sensitivity to
diltiazem or to any of the other
ingredients of the medicine.
∙ If you are suffering from low blood
pressure.
∙ If you are suffering from a very slow
heart rate - less than 50 beats per
minute.
∙ If you are suffering from heart failure or
from problems with blood flow to the
lungs - in these conditions, you may
experience breathlessness and swelling
of the ankles.
∙ If you are suffering from severe heart
problems, including irregular heart rate
(unless you have a pacemaker).
∙ If you are concomitantly receiving
dantrolene injections (for use in cases of
severe fever or severe muscle spasms -
see “If you are taking, or have recently
taken, other medicines” section).
∙ If you are taking a medicine that
contains

خصائص المنتج

DILITAZEM TEVA 30,60 Sub:12.2015, SZ, App: 30.06.2016
."רשואו קדבנ ונכותו תואירבה דרשמ י"ע
עבקנ הז ןולע טמרופ"
רושיא ךיראת
:
30.06.2016
“This leaflet format has been determined by the Ministry of Health
and the content thereof has been
checked and approved.” Date of approval:
30.06.2016
NAME OF THE MEDICINAL PRODUCT:
DILTIAZEM TEVA



PHARMACEUTICAL FORM:
Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
_DILTIAZEM TEVA 30 _
_Active Ingredient: _
Diltiazem hydrochloride 30 mg
_ _
_Others Ingredients _
Lactose
monohydrate,
hydroxypropyl
methylcellulose,
povidone,
magnesium
stearate, macrogol/peg 400, FD&C yellow #6/sunset yellow FCF aluminium
lake,
titanium dioxide, polysorbate 80, purified water.
_DILTIAZEM TEVA 60 _
_Active Ingredient: _
Diltiazem hydrochloride 60 mg
_ _
_Others Ingredients _
Lactose
monohydrate,
hydroxypropyl
methylcellulose,
povidone,
magnesium
stearate,
polysorbate
80,
FD&C
yellow
#6/sunset
yellow
FCF
aluminium
lake,
macrogol/peg 400, titanium dioxide, purified water.
CLINICAL PARTICULARS:
INDICATIONS
_Angina Pectoris due to Coronary Artery Spasm _
Diltiazem is indicated in the treatment of angina pectoris due to
coronary artery
spasm. It has been shown effective in the treatment of spontaneous
coronary artery
spasm presenting as Prinzmetal's variant angina (resting angina with
ST-segment
elevation occurring during attacks).
_Chronic Stable Angina (Classic Effort-Associated Angina) _
Diltiazem is indicated in the management of chronic stable angina. It
is also effective
in patients who cannot tolerate therapy with beta-blockers and/or
nitrates or who
remain
symptomatic
despite
adequate
doses
of
these
agents.
In
short-term
controlled trials, Diltiazem has been effective in reducing angina
frequency and
increasing
exercise
tolerance,
but
confirmation
of
sustained
effectiveness
is
incomplete.
DOSAGE AND ADMINISTRATION
Dosage should be individualized. Start with 30 mg 4 times daily,
before meals and
at bedti